Free Trial

Weiss Ratings Reiterates "Sell (E+)" Rating for Owens & Minor (NYSE:OMI)

Owens & Minor logo with Medical background

Owens & Minor (NYSE:OMI - Get Free Report)'s stock had its "sell (e+)" rating reaffirmed by stock analysts at Weiss Ratings in a report issued on Saturday,Weiss Ratings reports.

A number of other research analysts also recently issued reports on OMI. UBS Group set a $7.00 price objective on Owens & Minor in a research note on Wednesday, August 13th. Citigroup reissued a "buy" rating and set a $7.00 price objective (down from $11.00) on shares of Owens & Minor in a report on Tuesday, August 12th. Baird R W raised Owens & Minor from a "hold" rating to a "strong-buy" rating in a report on Friday, August 8th. Robert W. Baird decreased their price objective on Owens & Minor from $10.00 to $7.00 and set an "outperform" rating for the company in a report on Tuesday, August 12th. Finally, Bank of America decreased their price objective on Owens & Minor from $7.50 to $4.75 and set an "underperform" rating for the company in a report on Tuesday, August 12th. One research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, two have assigned a Hold rating and three have given a Sell rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Hold" and an average target price of $7.63.

Check Out Our Latest Research Report on OMI

Owens & Minor Trading Up 4.6%

Shares of OMI opened at $5.50 on Friday. Owens & Minor has a 52-week low of $4.34 and a 52-week high of $15.54. The business's fifty day moving average is $5.07 and its 200-day moving average is $6.55. The company has a debt-to-equity ratio of 3.32, a quick ratio of 0.83 and a current ratio of 0.86. The firm has a market cap of $425.13 million, a price-to-earnings ratio of -0.35 and a beta of 1.26.

Owens & Minor (NYSE:OMI - Get Free Report) last issued its quarterly earnings results on Monday, August 11th. The company reported $0.26 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.27 by ($0.01). Owens & Minor had a negative net margin of 13.78% and a positive return on equity of 26.59%. The business had revenue of $681.90 million during the quarter, compared to the consensus estimate of $2.73 billion. During the same quarter in the previous year, the business posted $0.36 EPS. The company's revenue for the quarter was up 3.3% on a year-over-year basis. Owens & Minor has set its FY 2025 guidance at 1.020-1.070 EPS. Equities analysts anticipate that Owens & Minor will post 1.51 EPS for the current fiscal year.

Insider Buying and Selling

In other news, major shareholder Coliseum Capital Management, L acquired 720,000 shares of the company's stock in a transaction that occurred on Tuesday, August 12th. The shares were acquired at an average price of $5.15 per share, for a total transaction of $3,708,000.00. Following the completion of the purchase, the insider owned 12,282,955 shares in the company, valued at approximately $63,257,218.25. This trade represents a 6.23% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink. Insiders purchased a total of 1,537,852 shares of company stock valued at $8,099,544 in the last quarter. 3.69% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Owens & Minor

Several institutional investors have recently made changes to their positions in the stock. Coliseum Capital Management LLC lifted its position in shares of Owens & Minor by 122.0% during the first quarter. Coliseum Capital Management LLC now owns 10,624,599 shares of the company's stock worth $95,940,000 after acquiring an additional 5,838,635 shares in the last quarter. Vanguard Group Inc. lifted its position in shares of Owens & Minor by 2.7% during the first quarter. Vanguard Group Inc. now owns 9,156,759 shares of the company's stock worth $82,686,000 after acquiring an additional 241,003 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its position in shares of Owens & Minor by 19.4% during the first quarter. Charles Schwab Investment Management Inc. now owns 2,752,960 shares of the company's stock worth $24,859,000 after acquiring an additional 447,917 shares in the last quarter. Paradigm Capital Management Inc. NY lifted its position in shares of Owens & Minor by 3,197.8% during the second quarter. Paradigm Capital Management Inc. NY now owns 1,978,700 shares of the company's stock worth $18,006,000 after acquiring an additional 1,918,700 shares in the last quarter. Finally, Invesco Ltd. increased its holdings in shares of Owens & Minor by 10.0% in the second quarter. Invesco Ltd. now owns 1,888,548 shares of the company's stock worth $17,186,000 after purchasing an additional 171,653 shares during the period. Hedge funds and other institutional investors own 98.04% of the company's stock.

Owens & Minor Company Profile

(Get Free Report)

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.

Featured Stories

Analyst Recommendations for Owens & Minor (NYSE:OMI)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Owens & Minor Right Now?

Before you consider Owens & Minor, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Owens & Minor wasn't on the list.

While Owens & Minor currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.